Elovl2 ablation demonstrates that systemic DHA is endogenously produced and is essential for lipid homeostasis in mice
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The potential role of endogenously synthesized PUFAs is a highly overlooked area. Elongation of very long-chain fatty acids (ELOVLs) in mammals is catalyzed by the ELOVL enzymes to which the PUFA elongase ELOVL2 belongs. To determine its in vivo function, we have investigated how ablation of ELOVL2, which is highly expressed in liver, affects hepatic lipid composition and function in mice. The Elovl2(-/-) mice displayed substantially decreased levels of 22:6(n-3), DHA, and 22:5(n-6), docosapentaenoic acid (DPA) n-6, and an accumulation of 22:5(n-3) and 22:4(n-6) in both liver and serum, showing that ELOVL2 primarily controls the elongation process of PUFAs with 22 carbons to produce 24-carbon precursors for DHA and DPAn-6 formation in vivo. The impaired PUFA levels positively influenced hepatic levels of the key lipogenic transcriptional regulator sterol-regulatory element binding protein 1c (SREBP-1c), as well as its downstream target genes. Surprisingly, the Elovl2(-/-) mice were resistant to hepatic steatosis and diet-induced weight gain, implying that hepatic DHA synthesis via ELOVL2, in addition to controlling de novo lipogenesis, also regulates lipid storage and fat mass expansion in an SREBP-1c-independent fashion. The changes in fatty acid metabolism were reversed by dietary supplementation with DHA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genome-wide perspective of genetic variation in human metabolism
Illig, T., Gieger, C., Zhai, G., Römisch-Margl, W., Wang-Sattler, R., Prehn, C., Altmaier, E., Kastenmüller, G., Kato, B. S., Mewes, H.-W., et al. (2010) · Nature Genetics · doi:10.1038/ng.507 · Cited by 653
Genome-Wide Association Study of Plasma Polyunsaturated Fatty Acids in the InCHIANTI Study
Tanaka, T., Shen, J., Abecasis, G. R., Kisialiou, A., Ordovas, J. M., Guralnik, J. M., Singleton, A., Bandinelli, S., Cherubini, A., Arnett, D., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000338 · Cited by 418
Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression
Sekiya, M., Yahagi, N., Matsuzaka, T., Najima, Y., Nakakuki, M., Nagai, R., Ishibashi, S., Osuga, J.-I., Yamada, N., & Shimano, H. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.028 · Cited by 415
ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis
Ohno, Y., Suto, S., Yamanaka, M., Mizutani, Y., Mitsutake, S., Igarashi, Y., Sassa, T., & Kihara, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005572107 · Cited by 382
Kim, H.-J., Takahashi, M., & Ezaki, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25892 · Cited by 377
Zadravec, D., Tvrdik, P., Guillou, H., Haslam, R., Kobayashi, T., Napier, J. A., Capecchi, M. R., & Jacobsson, A. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011346 · Cited by 146
Self-citationGregory, M. K., Cleland, L. G., & James, M. J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m041368 · Cited by 64
Cited by
Chiurchiù, V., Leuti, A., Dalli, J., Jacobsson, A., Battistini, L., Maccarrone, M., & Serhan, C. N. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf7483 · Cited by 359
Self-citationLipid droplets and polyunsaturated fatty acid trafficking: Balancing life and death
Danielli, M., Perne, L., Jarc Jovičić, E., & Petan, T. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1104725 · Cited by 180
Identification and evaluation of age-correlated DNA methylation markers for forensic use
Park, J.-L., Kim, J. H., Seo, E., Bae, D. H., Kim, S.-Y., Lee, H.-C., Woo, K.-M., & Kim, Y. S. (2016) · Forensic Science International: Genetics · doi:10.1016/j.fsigen.2016.03.005 · Cited by 174
“2 is involved in the elongation of 22-carbon polyunsaturated fatty acids to 24-carbon precursors for docosahexaenoic acid and docosapentaenoic acid formation [41].”
BackgroundProtectin D1 n-3 DPA and resolvin D5 n-3 DPA are effectors of intestinal protection
Gobbetti, T., Dalli, J., Colas, R. A., Federici Canova, D., Aursnes, M., Bonnet, D., Alric, L., Vergnolle, N., Deraison, C., Hansen, T. V., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617290114 · Cited by 168
“To establish the impact of endogenous n-3 DPA-derived mediators in gastrointestinal protection, we assessed the profiles in animals with reduced expression of fatty acid elongase 2 (ELOVL2) (17), the enzyme that converts n-3 DPA to DHA (Fig.”
BackgroundInfluentialThe lipid elongation enzyme ELOVL2 is a molecular regulator of aging in the retina
Chen, D., Chao, D. L., Rocha, L., Kolar, M., Nguyen Huu, V. A., Krawczyk, M., Dasyani, M., Wang, T., Jafari, M., Jabari, M., et al. (2020) · Aging Cell · doi:10.1111/acel.13100 · Cited by 109
Apocryphal FADS2 activity promotes fatty acid diversification in cancer
Young, R. S. E., Bowman, A. P., Williams, E. D., Tousignant, K. D., Bidgood, C. L., Narreddula, V. R., Gupta, R., Marshall, D. L., Poad, B. L. J., Nelson, C. C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108738 · Cited by 109
rs953413 Regulates Polyunsaturated Fatty Acid Metabolism by Modulating ELOVL2 Expression
Pan, G., Cavalli, M., Carlsson, B., Skrtic, S., Kumar, C., & Wadelius, C. (2020) · iScience · doi:10.1016/j.isci.2019.100808 · Cited by 26
Metadata
- Authors
- Pauter, A. M., Olsson, P., Asadi, A., Herslöf, B., Csikasz, R. I., Zadravec, D., & Jacobsson, A.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 55
- Issue
- 4
- Pages
- 718-728
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2172099178
- Cited by
- 152
- References
- 7
- FWCI
- 8.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.